Accolade Announces Participation in June Investor Conferences
Get Alerts ACCD Hot Sheet
Join SI Premium – FREE
SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com.
- Wednesday, June 8 at 4:10 pm ET. Stifel 2022 Cross Sector Insight Conference in Boston
- Thursday, June 9 at 3:00 pm ET. 42nd Annual William Blair Growth Stock Conference in Chicago
- Thursday, June 16 at 12:20 pm ET. Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA
About Accolade, Inc.
Accolade (Nasdaq: ACCD) provides millions of people and their families with an exceptional healthcare experience that is personal, data driven and value based to help every person live their healthiest life. Accolade solutions combine virtual primary care, mental health support and expert medical opinion services with intelligent technology and best-in-class care navigation. Accolade's Personalized Healthcare approach puts humanity back in healthcare by building relationships that connect people and their families to the right care at the right time to improve outcomes, lower costs and deliver consumer satisfaction. Accolade consistently receives consumer satisfaction ratings over 90%. For more information, visit accolade.com.
Investor Contact:
Todd Friedman, Investor Relations, [email protected]
Source: Accolade
Source: Accolade, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Unveils CS-4: Up to 30 Times Faster than GPU-based Solutions
- Cotchett, Pitre & McCarthy Announces Bank of America Must Face Trial in California Pandemic Unemployment Benefits Litigation
- Chicago Divorce Attorney Michael Ian Bender Explains College Expense Obligations Under Illinois Section 513
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stifel, William Blair, Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share